Bioheart, Inc.

13794 NW 4th Street, Suite 212
Sunrise, Florida 33325
Telephone: (954)-835-1500
Fax: (954)-845-9976
bioheart@bioheartinc.com

Latest News

Bioheart Launches new website Welcome to our newly designed website. Latest news coming soon! More Info >

Bioheart Inc. to Participate in the 2009 World Stem Cell Summit on September 23rd
SUNRISE, Fla., Sept. 10 /PRNewswire-FirstCall/ -- Bioheart, Inc., (OTC Bulletin Board: BHRT - News) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and other cardiovascular diseases announced today More Info >

ON THE HORIZON

Bioheart Strengthens Executive Team in Order to Accelerate Business Plan and Enhance Its Position in the Cardiovascular Stem Cell Therapy Industry

Read Article >

REGEN Trial

United States FDA Clears the REGEN Trial to Test Bioheart's Combination Gene and Stem Cell Therapy in Heart Failure Patients

Read Article >

Welcome to Bioheart Inc.

Bioheart is a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic, acute heart damage, and peripheral vascular disease

Latest News Release

Bioheart Elects Lee Jones to Its Board of Directors

Read Press Release

Recovery of Damaged Heart Possible Through Stem Cells Therapy

Read Press Release

Positive Results in the MARVEL Phase II/ III Clinical Trial

Read Press Release

Bioheart Makes Breakthrough in Cardiovascular Therapy with Stem Cells Obtained from Fat Tissue

Read Press Release

Scientific Panel Discussion

Live Webcast - Thursday, June 4, 2009.

View Webcast Slides

 

Listen to Webcast Audio

 

Shareholder Update

Latest SEC Filing: 8-K Current Report, December 1, 2009

Bioheart, Inc 10Q, November 13, 2009

10-Q Quarterly Report, August 18, 2009